Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.06 USD | -0.43% | -0.06% | -0.86% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.86% | 7.7B | |
+7.50% | 111B | |
+11.34% | 106B | |
-12.35% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.08% | 16.81B | |
+38.36% | 12.54B | |
-24.40% | 8.09B |
- Stock Market
- Equities
- CERE Stock
- News Cerevel Therapeutics Holdings, Inc.
- Morgan Stanley Adjusts Price Target on Cerevel Therapeutics to $42 From $46, Maintains Overweight Rating